C07K 14/60
Growth hormone-releasing factor [gh-rf], i.e. somatoliberin
Official title: Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
C07K14/60 (Growth hormone-releasing factor [gh-rf], i.e. somatoliberin) appears on 237 US grants and 187 published applications in this corpus.
Search patents in C07K- Granted patents
- 237
- Published applications
- 187
- Assignees
- 124
- Inventors
- 416
- Latest grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 9 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 5 | 0 |
| 1986 | 10 | 0 |
| 1987 | 8 | 0 |
| 1988 | 6 | 0 |
| 1989 | 11 | 0 |
| 1990 | 2 | 0 |
| 1991 | 4 | 0 |
| 1992 | 7 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 9 | 0 |
| 1997 | 12 | 0 |
| 1998 | 14 | 0 |
| 1999 | 8 | 0 |
| 2000 | 8 | 0 |
| 2001 | 2 | 1 |
| 2002 | 4 | 3 |
| 2003 | 1 | 7 |
| 2004 | 3 | 9 |
| 2005 | 1 | 17 |
| 2006 | 4 | 8 |
| 2007 | 7 | 5 |
| 2008 | 9 | 14 |
| 2009 | 5 | 18 |
| 2010 | 4 | 8 |
| 2011 | 7 | 11 |
| 2012 | 13 | 4 |
| 2013 | 9 | 7 |
| 2014 | 4 | 10 |
| 2015 | 9 | 9 |
| 2016 | 9 | 4 |
| 2017 | 2 | 14 |
| 2018 | 5 | 5 |
| 2019 | 2 | 5 |
| 2020 | 6 | 6 |
| 2021 | 1 | 4 |
| 2022 | 0 | 2 |
| 2023 | 1 | 12 |
| 2024 | 2 | 2 |
| 2025 | 0 | 1 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of producing Shiga toxin B-subunit (STxB) monomers and oligomers, and uses thereof20 Jan 2026US 12,527,854 B2Aphp (Assistance Publique - HôPitaux De Paris)
- Recombinant protein comprising multiple multi-peptide sets, pharmaceutical composition comprising the recombinant protein, and method for preparing the recombinant protein13 Jan 2026US 12,522,642 B2
- Methods and systems for solid phase peptide synthesis23 Jul 2024US 12,043,646 B2Massachusetts Institute of Technology
- Treating inflammatory lung disease28 May 2024US 11,993,640 B2The United States Government as represented by the Department of Veterans Affairs
- Methods and systems for solid phase peptide synthesis21 Feb 2023US 11,584,776 B2Massachusetts Institute of Technology
- Methods of producing shiga toxin b-subunit (stxb) monomers and oligomers, and uses thereof21 May 2026US 2026/0137765 A1Aphp (Assistance Publique - HôPitaux De Paris)
- Constructs and methods for increased expression of polypeptides20 Feb 2025US 2025/0059550 A1
- Treating Inflammatory Lung Disease29 Aug 2024US 2024/0287153 A1The United States Government as represented by the Department of Veterans Affairs
- Effect of ghrh antagonists in diabetes and obesity6 Jun 2024US 2024/0181015 A1Augusta University Research Institute, Inc.
- Method for extending half-life of a protein19 Oct 2023US 2023/0331769 A1Ubiprotein, Corp.
Most cited
By later US patents
- Albumin fusion proteins comprising GLP-1 polypeptides198US 7,141,547 B2Human Genome Sciences, Inc. · 2006
- Highly potent agonists of growth hormone releasing hormone152US 5,792,747 AThe Administrators of the Tulane Educational Fund · 1998
- Albumin fusion proteins96US 7,592,010 B2Delta Biotechnology Limited · 2009
- Injectable extended release formulations and methods88US 5,352,662 A1994
- Codon optimized synthetic plasmids75US 7,316,925 B2VGX Pharmaceuticals, Inc. · 2008